Endpoints News 2026-01-31 Big Pharma earnings kick off; Third-round IRA drugs selected; Hengrui’s trailblazing moment; and more
Endpoints News 2026-01-30 FDA says it explained issues early on for Corcept's rejected Cushing's syndrome drug
Endpoints News 2026-01-30 Janux hires CMO after T cell engager deal with Bristol Myers; A batch of appointments at Lexeo
Endpoints News 2026-01-29 Sanofi says its €15B dealmaking budget, R&D spend should help ease looming Dupixent patent cliff